Interventional Oncology Devices | Market Insights | Latin America (Supplemental) | 2021
Although the Latin American interventional oncology device market will be hindered in the immediate term by the impact of the COVID-19 pandemic, the market will resume moderate growth once the market recovers, driven by an increasing patient population, adoption of premium-priced devices, and the introduction of new devices in the countries covered. However, cost constraints in the region’s publicly funded health care systems will limit the pace of revenue expansion.
This Medtech 360 Report provides high-level market metrics for interventional oncology devices in the Latin American region, including country-level data for major countries and aggregate data for the rest of Latin America, across a 10-year period.
Related Medtech Insights Reports
Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Latin America (Supplemental)
The Latin American EP mapping and ablation device market will experience strong growth through 2033, driven by the increasing prevalence of cardiac arrhythmia in Latin American countries, improved…
